EUVIMEDEUVIMED entdecken
Crossref

New oral anticoagulants for stroke prevention in atrial fibrillation: Evidence from phase III clinical trials

Pushpraj Patel, Nishant Sangole

Journal of Indian College of Cardiology · 2012

DOI: 10.1016/j.jicc.2012.06.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Indian College of Cardiology, 2012. Verfasst von Pushpraj Patel und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) is the most common clinically significant cardiac arrhythmia. It increases both, the risk and severity of strokes and is associated with substantial morbidity, mortality, decreased quality of life, and related health care cost and care giver burden. Ischemic strokes among patients with AF are commonly caused by cardioemboli, most commonly from within the left atrial appendage. Vitamin K antagonist (VKA), warfarin has a long history of benefit and has become the gold standard medication for the prevention of ischemic stroke in patients with atrial fibrillation. However due to significant underutilization and several limitations of VKA, novel oral anticoagulants are being developed. Recently, new oral anticoagulant drugs that act directly by inhibiting activated coagulation factors such as factor X or thrombin have been developed and investigated in phase III clinical trials. Our review focuses on clinical evidence of direct thrombin inhibitor, dabigatran, and FXa inhibitors, rivaroxaban and apixaban in phase III trials for prevention of stroke and systemic embolism in AF.

Zitieren

APA

Patel, P., & Sangole, N. (2012). New oral anticoagulants for stroke prevention in atrial fibrillation: Evidence from phase III clinical trials. Journal of Indian College of Cardiology. https://doi.org/10.1016/j.jicc.2012.06.004

Vancouver

Patel P, Sangole N. New oral anticoagulants for stroke prevention in atrial fibrillation: Evidence from phase III clinical trials. Journal of Indian College of Cardiology. 2012. doi:10.1016/j.jicc.2012.06.004

BibTeX
@article{Patel2012,
  author = {Patel, Pushpraj and Sangole, Nishant},
  title = {New oral anticoagulants for stroke prevention in atrial fibrillation: Evidence from phase III clinical trials},
  journal = {Journal of Indian College of Cardiology},
  year = {2012},
  doi = {10.1016/j.jicc.2012.06.004}
}
Kostenlos starten →